Kura Oncology, Inc. (KURA)
13.15
+0.04
(+0.31%)
USD |
NASDAQ |
Sep 03, 13:42
Kura Oncology Net Income (Annual) : -278.67M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -278.67M |
| December 31, 2024 | -173.98M |
| December 31, 2023 | -152.63M |
| December 31, 2022 | -135.84M |
| December 31, 2021 | -130.47M |
| December 31, 2020 | -89.62M |
| Date | Value |
|---|---|
| December 31, 2019 | -63.14M |
| December 31, 2018 | -60.45M |
| December 31, 2017 | -35.43M |
| December 31, 2016 | -27.56M |
| December 31, 2015 | -22.62M |
| December 31, 2014 | -3.671M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Inovio Pharmaceuticals, Inc. | -84.95M |
| Fortress Biotech, Inc. | -32.92M |
| Syndax Pharmaceuticals, Inc. | -285.42M |
| Spero Therapeutics, Inc. | 8.572M |
| Gossamer Bio, Inc. | -170.37M |